MIPEP Activators
MIPEP Activators are a class of chemical compounds that specifically enhance the functional activity of MIPEP, a mitochondrial intermediate peptidase. These activators primarily function by modulating intracellular ion levels, specifically calcium and sodium ions. Verapamil, Nifedipine, Dantrolene, Ziconotide, and Ethanol, for example, are known calcium channel blockers that reduce intracellular calcium levels. Since MIPEP requires calcium for its peptidase activity, a decrease in calcium levels can indirectly enhance MIPEP activity by reducing substrate competition.
Additionally, certain MIPEP Activators function by altering intracellular sodium levels. Riluzole, Lidocaine, Tetrodotoxin, and Amiloride, for instance, are known to inhibit sodium channels, reducing intracellular sodium levels. Similarly, Ouabain and Digoxin inhibit the sodium-potassium pump, altering the intracellular ion balance. Since sodium can compete with substrates of MIPEP, reducing its levels can indirectly enhance MIPEP activity. Furthermore, Spironolactone, an aldosterone antagonist, affects ion balance and can indirectly enhance MIPEP activity by reducing intracellular sodium levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that reduces intracellular calcium levels. Since MIPEP requires calcium for its peptidase activity, a decrease in calcium levels can indirectly enhance MIPEP activity by reducing substrate competition. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, another calcium channel blocker, decreases intracellular calcium levels. This can indirectly enhance the functional activity of MIPEP by reducing competition for its substrates. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene inhibits the release of calcium from the sarcoplasmic reticulum, indirectly enhancing MIPEP activity by reducing substrate competition. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Riluzole inhibits voltage-gated sodium channels, reducing intracellular sodium levels. Since sodium can compete with substrates of MIPEP, lowering its levels can indirectly enhance MIPEP activity. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine is a sodium channel blocker that reduces intracellular sodium levels. This can indirectly enhance MIPEP activity by reducing competition with its substrates. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the sodium-potassium pump, which can indirectly enhance MIPEP activity by altering intracellular ion balance and reducing substrate competition. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin inhibits the sodium-potassium pump, altering the intracellular ion balance and potentially reducing competition for MIPEP substrates, thereby indirectly enhancing its activity. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride inhibits sodium channels and the sodium-hydrogen exchanger, reducing intracellular sodium levels. This can indirectly enhance MIPEP activity by reducing competition for substrates. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone is an aldosterone antagonist that affects ion balance. By reducing intracellular sodium levels, it can indirectly enhance MIPEP activity by reducing substrate competition. | ||||||